Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pfister

Showing results (181-190 of 288) with videos related to

Pageof 29
Sort By:
Oral Oncology|August 19, 2014
Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)Lauren Q Shapiro, Eric J Sherman, Nadeem Riaz, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancerL B Harrison, D G Pfister, D E Fass, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2009
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastasesJacobus F A Jansen, Heiko Schöder, Nancy Y Lee, et al.
Oral Oncology|May 25, 2024
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancerAntoine Desilets, David G Pfister, Sarah Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003David G Pfister, David H Johnson, Christopher G Azzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical OncologyC E Desch, A B Benson, T J Smith, et al.
Thyroid : Official Journal of the American Thyroid Association|November 29, 2012
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinomaEric J Sherman, Yungpo Bernard Su, Ashima Lyall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelinesA B Benson, C E Desch, P J Flynn, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 1, 1994
Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancerD H Kraus, D G Pfister, L B Harrison, et al.
Cancer|March 15, 2012
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancerMatthew G Fury, Nancy Y Lee, Eric Sherman, et al.
Pageof 29

Showing results (181-190 of 288) with videos related to

Sort By:
Pageof 29
Oral Oncology|August 19, 2014
Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC)Lauren Q Shapiro, Eric J Sherman, Nadeem Riaz, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1991
Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancerL B Harrison, D G Pfister, D E Fass, et al.
International Journal of Radiation Oncology, Biology, Physics|November 13, 2009
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastasesJacobus F A Jansen, Heiko Schöder, Nancy Y Lee, et al.
Oral Oncology|May 25, 2024
A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancerAntoine Desilets, David G Pfister, Sarah Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003David G Pfister, David H Johnson, Christopher G Azzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical OncologyC E Desch, A B Benson, T J Smith, et al.
Thyroid : Official Journal of the American Thyroid Association|November 29, 2012
Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinomaEric J Sherman, Yungpo Bernard Su, Ashima Lyall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelinesA B Benson, C E Desch, P J Flynn, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|July 1, 1994
Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancerD H Kraus, D G Pfister, L B Harrison, et al.
Cancer|March 15, 2012
A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancerMatthew G Fury, Nancy Y Lee, Eric Sherman, et al.
Pageof 29